These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8105686)
1. High prevalence of the point mutation in exon 6 of the xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia. Nishigori C; Zghal M; Yagi T; Imamura S; Komoun MR; Takebe H Am J Hum Genet; 1993 Nov; 53(5):1001-6. PubMed ID: 8105686 [TBL] [Abstract][Full Text] [Related]
2. Three nonsense mutations responsible for group A xeroderma pigmentosum. Satokata I; Tanaka K; Miura N; Narita M; Mimaki T; Satoh Y; Kondo S; Okada Y Mutat Res; 1992 Mar; 273(2):193-202. PubMed ID: 1372102 [TBL] [Abstract][Full Text] [Related]
3. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients. Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089 [TBL] [Abstract][Full Text] [Related]
4. Compound heterozygosity for the Xeroderma pigmentosum complementation group A gene associated with a mild phenotype. Negishi I; Kato G; Moriwaki S; Ishikawa O Eur J Dermatol; 2002; 12(6):536-9. PubMed ID: 12459522 [TBL] [Abstract][Full Text] [Related]
5. Correlation of the clinical manifestations and gene mutations of Japanese xeroderma pigmentosum group A patients. Kondoh M; Ueda M; Ichihashi M Br J Dermatol; 1995 Oct; 133(4):579-85. PubMed ID: 7577588 [TBL] [Abstract][Full Text] [Related]
6. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan. Nishigori C; Moriwaki S; Takebe H; Tanaka T; Imamura S Arch Dermatol; 1994 Feb; 130(2):191-7. PubMed ID: 7905727 [TBL] [Abstract][Full Text] [Related]
7. Aberrant splicing and truncated-protein expression due to a newly identified XPA gene mutation. Sato M; Nishigori C; Yagi T; Takebe H Mutat Res; 1996 Feb; 362(2):199-208. PubMed ID: 8596539 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a splicing mutation in group A xeroderma pigmentosum. Satokata I; Tanaka K; Miura N; Miyamoto I; Satoh Y; Kondo S; Okada Y Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9908-12. PubMed ID: 1702221 [TBL] [Abstract][Full Text] [Related]
9. Identification of splicing mutations of the last nucleotides of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum. Satokata I; Tanaka K; Yuba S; Okada Y Mutat Res; 1992 Mar; 273(2):203-12. PubMed ID: 1372103 [TBL] [Abstract][Full Text] [Related]
10. Severe neurological abnormalities associated with a mutation in the zinc-finger domain in a group A xeroderma pigmentosum patient. Maeda T; Sato K; Minami H; Taguchi H; Yoshikawa K Br J Dermatol; 1994 Oct; 131(4):566-70. PubMed ID: 7947212 [TBL] [Abstract][Full Text] [Related]
11. Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein. States JC; McDuffie ER; Myrand SP; McDowell M; Cleaver JE Hum Mutat; 1998; 12(2):103-13. PubMed ID: 9671271 [TBL] [Abstract][Full Text] [Related]
12. Molecular basis of group A xeroderma pigmentosum: a missense mutation and two deletions located in a zinc finger consensus sequence of the XPAC gene. Satokata I; Tanaka K; Okada Y Hum Genet; 1992 Mar; 88(6):603-7. PubMed ID: 1339397 [TBL] [Abstract][Full Text] [Related]
13. [Neurological manifestations and molecular basis of group A xeroderma pigmentosum]. Mimaki T; Tanaka K; Nagai A; Mino M Nihon Rinsho; 1993 Sep; 51(9):2488-93. PubMed ID: 8105118 [TBL] [Abstract][Full Text] [Related]
14. PCR-RFLP analysis as an aid to genetic counseling of families of Japanese patients with group A xeroderma pigmentosum. Maeda T; Sato K; Minami H; Taguchi H; Yoshikawa K J Invest Dermatol; 1997 Sep; 109(3):306-9. PubMed ID: 9284095 [TBL] [Abstract][Full Text] [Related]
15. Severe phenotypes in two Tunisian families with novel XPA mutations: evidence for a correlation between mutation location and disease severity. Messaoud O; Rekaya MB; Ouragini H; Benfadhel S; Azaiez H; Kefi R; Gouider-Khouja N; Mokhtar I; Amouri A; Boubaker MS; Zghal M; Abdelhak S Arch Dermatol Res; 2012 Mar; 304(2):171-6. PubMed ID: 22081045 [TBL] [Abstract][Full Text] [Related]
16. A novel XPA gene mutation and its functional analysis in a Japanese patient with xeroderma pigmentosum group A. Tanioka M; Budiyant A; Ueda T; Nagano T; Ichihashi M; Miyachi Y; Nishigori C J Invest Dermatol; 2005 Aug; 125(2):244-6. PubMed ID: 16098033 [TBL] [Abstract][Full Text] [Related]
17. Allelic heterogeneity in group A xeroderma pigmentosum. Mimaki T; Tanaka K; Okada Y; Minami R; Tachi N; Nagai A; Mino M Acta Neurol Scand; 1992 May; 85(5):327-30. PubMed ID: 1621494 [TBL] [Abstract][Full Text] [Related]
18. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A. Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909 [TBL] [Abstract][Full Text] [Related]
19. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients. Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG. Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]